Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Immuno-Biological Laboratories Co., Ltd. (TYO:4570)
Japan
· Delayed Price · Currency is JPY
Full Chart
Watchlist
Alerts
Compare
1,007.00
-5.00 (-0.49%)
Jun 3, 2026, 3:30 PM JST
Overview
Financials
Statistics
Dividends
History
Profile
Chart
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Quarterly
TTM
TYO:4570 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Mil
Millions
Data
Data Source
JPY
JPY
More
Download
Full Width
Fiscal Year
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
Period Ending
Mar '26
Mar 31, 2026
Mar '25
Mar 31, 2025
Mar '24
Mar 31, 2024
Mar '23
Mar 31, 2023
Mar '22
Mar 31, 2022
Revenue
1,004
969
816
794
647
Revenue Growth (YoY)
3.61%
18.75%
2.77%
22.72%
7.47%
Cost of Revenue
298
335
300
268
271
Gross Profit
706
634
516
526
376
Selling, General & Admin
299
300
282
289
310
Research & Development
120
119
129
179
188
Operating Expenses
425
425
406
474
498
Operating Income
281
209
110
52
-122
Interest Expense
-1
-1
-1
-1
-
Interest & Investment Income
1
-
-
1
-
Earnings From Equity Investments
-
-
-
-203
-152
Currency Exchange Gain (Loss)
6
-3
8
4
3
Other Non Operating Income (Expenses)
14
5
7
12
28
EBT Excluding Unusual Items
301
210
124
-135
-243
Gain (Loss) on Sale of Investments
-
-
-
-130
-
Asset Writedown
-
-
-
-14
-7
Other Unusual Items
-
-
-
-1
-
Pretax Income
301
210
124
-280
-250
Income Tax Expense
-28
-39
-62
9
8
Net Income
329
249
186
-289
-258
Net Income to Common
329
249
186
-289
-258
Net Income Growth
32.13%
33.87%
-
-
-
Shares Outstanding (Basic)
9
9
9
9
9
Shares Outstanding (Diluted)
9
9
9
9
9
EPS (Basic)
35.33
26.74
19.97
-31.03
-27.70
EPS (Diluted)
35.33
26.74
19.97
-31.03
-27.70
EPS Growth
32.13%
33.87%
-
-
-
Free Cash Flow
268
124
117
26
-93
Free Cash Flow Per Share
28.78
13.31
12.56
2.79
-9.99
Gross Margin
70.32%
65.43%
63.23%
66.25%
58.11%
Operating Margin
27.99%
21.57%
13.48%
6.55%
-18.86%
Profit Margin
32.77%
25.70%
22.79%
-36.40%
-39.88%
Free Cash Flow Margin
26.69%
12.80%
14.34%
3.28%
-14.37%
EBITDA
299
224
112
-
-
EBITDA Margin
29.78%
23.12%
13.73%
-
-
D&A For EBITDA
18
15
2
-
-
EBIT
281
209
110
52
-122
EBIT Margin
27.99%
21.57%
13.48%
6.55%
-18.86%